Valink Therapeutics (private company)
See something wrong or missing? Let us know
Offices:London
Business model:B2BSAAS
Valink Therapeutics (formerly LiliumX) developed a process for discovering new bispecific antibodies against cancer by using a modular protein platform, rapidly generating and testing thousands of candidate bispecifics using robotic screening and big data analysis to discover bispecific lead assets with entirely new modes of action.
Investors:
we tracked 8 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 7.92M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Valink Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Combinostics
90%
|
|
![]() |
Globus AI
90%
|
|
![]() |
Skin Analytics
90%
|
|
![]() |
Clustermarket
90%
|
|
![]() |
Floy
90%
|
|
![]() |
Teton.ai
87%
|
|
![]() |
Luminate Medical
87%
|
|
![]() |
Corti Labs
85%
|
|
![]() |
Psyomics
85%
|
|
![]() |
DeepSpin
85%
|
|